Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
about
Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter speciesH pylori antibiotic resistance: prevalence, importance, and advances in testingAspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agentsMycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infectionTreatment of Helicobacter pylori infection: current status and future concepts.Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.Mutation frequency and biological cost of antibiotic resistance in Helicobacter pyloriBactericidal activities of antibiotics against intracellular Francisella tularensis.Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutationsRoles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole.Second-line rescue therapy of helicobacter pylori infection.Helicobacter pylori interstrain restriction-modification diversity prevents genome subversion by chromosomal DNA from competing strains.Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pyloriSeven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication14C-urea breath test in patients undergoing anti-tuberculosis therapyHelicobacter pylori infection and respiratory diseases: a review.Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pyloriHelicobacter pylori resistance to rifabutin in the last 7 years.Helicobacter pylori detection and antimicrobial susceptibility testing.Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.Helicobacter pylori eradication therapy: A review of current trends.Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study."Rescue" regimens after Helicobacter pylori treatment failure.Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Eradication of Helicobacter pylori Infection.Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene.Third-line rescue therapy for Helicobacter pylori infection.World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.Current Status of the Third-Line Helicobacter pylori Eradication.
P2860
Q21146381-9DCF47AB-658F-4706-BF01-E516E80BEBDDQ24685864-8718BDDB-4A0A-448F-91F4-9BD4BE67B943Q28195352-09CDC483-5D4D-43BF-9462-F6662071B5D1Q30385967-FE63E98A-7B22-442E-AA2C-04EF6C36278FQ33291670-4D3BABFF-9384-45C0-BEE4-EFFA5492DEBCQ33594850-100B8C1A-1531-447E-B4EC-3E0933C5C3AEQ33916743-B336D796-2FC5-4F53-BBB2-DA38AE4BCA5CQ33952076-18A0C5BF-D297-41C4-97B8-7DCAC4A7EF41Q33981024-E035D77A-EC39-48A9-813A-41A9D34E6BB6Q33989370-C003D5E0-50E9-4CD0-84FD-38BDF0B2C7D5Q33996752-91249887-8B1A-4F2F-9D03-8155CBA2153CQ34409114-215CB85C-EA87-4D6D-846A-EF667DCE2A41Q34446640-BB7F8659-D9E4-4DB5-B5BE-0C44BEF16E5AQ34725597-9FDB841C-7089-4552-ACA0-9486051CA495Q34823645-B08E99D5-991F-41FC-BE2E-9E7AABE5F844Q34932701-F3B3C081-B54D-4405-B90B-21570EAC3312Q35011442-F52F5C6A-9A56-4DE5-A576-ED4188C303FCQ35036962-E99B69C7-81BD-498A-B98B-D7804F496AB4Q35104855-067D55CF-9273-40EE-B09B-FBC7E6D11790Q35363984-6E02E68A-D660-4906-A88E-EC59056F85FCQ35783436-4B728119-D074-4130-80FB-898BDDE8EF2BQ35997133-5814528B-11B2-4E4A-9039-8E5DB8AF8FD0Q36385174-E586E211-4D3F-4067-8BA9-4A9845DEEC50Q36817663-874E8E7B-3578-4EBD-A65A-1954D32B034EQ37045762-90CEA163-4514-4619-ADA9-E933B5B303AAQ37273653-6063333F-A76E-4E46-9625-9B7DEE086AA0Q37340339-DFD5D73B-518B-4396-A585-0F254BA2AF4EQ37378899-2158514A-9893-456F-89AF-8A9BB3B888F4Q37591509-9E739579-2A06-4248-9933-0D13995B4176Q38029324-07FFA376-3701-4F0F-8A66-B926D0EE7743Q38833959-73AFD773-8579-4BF1-91E5-2335ED1E170CQ39473557-3CC29194-390E-4F6A-8AF2-BE9A2C4F2C5AQ39474224-11DA1191-9DF8-47E5-8454-75B95764C78CQ39475246-480541F5-DDC5-4010-B6EE-B8589AFF7246Q39475702-2E2F6E53-C752-446B-BB0A-6D8F2E81DBCFQ39476503-D3EE5D7C-5B1F-477D-8254-3FFDD8537A6DQ39500646-0CD92D0F-D5E8-4AAE-984F-1FB76D7E4702Q42726333-871DA2EC-BEB1-46A4-877C-2FEC3F0CB11EQ48600558-3F82B145-8214-4C1C-B8DB-97C310E9D32FQ55056772-93EEAD82-1B29-4EDE-844A-4DBFFD9F9641
P2860
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@en
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@nl
type
label
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@en
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@nl
prefLabel
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@en
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@nl
P2093
P2860
P1476
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
@en
P2093
P2860
P304
P407
P577
1999-06-01T00:00:00Z